Sichuan Kelun Pharmaceutical Co., Ltd.
SZSE:002422.SZ
26.05 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 21,812.414 | 21,453.929 | 18,912.653 | 17,277.408 | 16,464.201 | 17,636.267 | 16,351.79 | 11,434.949 | 8,565.943 | 7,763.34 | 8,023.421 | 6,831.282 | 5,885.279 | 5,147.849 | 4,026.4 | 3,245.985 | 2,621.391 | 2,029.327 |
| Cost of Revenue
| 10,536.821 | 10,290.97 | 8,959.199 | 7,660.152 | 7,532.912 | 7,022.557 | 6,612.152 | 5,567.765 | 4,854.666 | 4,505.536 | 4,607.807 | 3,712.055 | 3,374.229 | 2,944.997 | 2,373.501 | 1,991.066 | 1,673.006 | 1,297.557 |
| Gross Profit
| 11,275.594 | 11,162.959 | 9,953.454 | 9,617.255 | 8,931.289 | 10,613.71 | 9,739.638 | 5,867.184 | 3,711.278 | 3,257.804 | 3,415.615 | 3,119.226 | 2,511.05 | 2,202.852 | 1,652.898 | 1,254.919 | 948.385 | 731.77 |
| Gross Profit Ratio
| 0.517 | 0.52 | 0.526 | 0.557 | 0.542 | 0.602 | 0.596 | 0.513 | 0.433 | 0.42 | 0.426 | 0.457 | 0.427 | 0.428 | 0.411 | 0.387 | 0.362 | 0.361 |
| Reseach & Development Expenses
| 2,170.539 | 1,946.735 | 1,795.088 | 1,736.587 | 1,527.331 | 1,285.867 | 885.231 | 712.213 | 547.44 | 434.163 | 312.351 | 300.058 | 186.545 | 136.43 | 71.437 | 34.914 | 10.427 | 11.035 |
| General & Administrative Expenses
| 399.021 | 382.891 | 311.688 | 319.977 | 294.867 | 213.213 | 160.864 | 125.035 | 183.119 | 165.879 | 152.47 | 110.009 | 97.239 | 81.611 | 84.597 | 49.748 | 45.435 | 47.653 |
| Selling & Marketing Expenses
| 3,492.619 | 4,449.718 | 4,685.948 | 5,022.333 | 4,882.545 | 6,550.305 | 5,987.227 | 3,073.855 | 1,254.483 | 1,027.937 | 1,048.872 | 887.039 | 696.745 | 692.364 | 592.444 | 500.889 | 394.464 | 311.085 |
| SG&A
| 3,891.64 | 4,832.61 | 4,997.636 | 5,342.31 | 5,177.412 | 6,763.519 | 6,148.091 | 3,198.89 | 1,437.602 | 1,193.816 | 1,201.343 | 997.048 | 793.985 | 773.975 | 677.041 | 550.637 | 439.899 | 358.739 |
| Other Expenses
| 787.093 | -65.9 | 626.896 | 829.694 | 590.599 | 753.48 | -22.795 | -15.556 | 63.955 | 112.095 | 75.808 | 146.647 | 138.167 | 60.117 | 30.883 | 26.013 | 2.592 | 9.961 |
| Operating Expenses
| 6,849.272 | 7,508.816 | 7,419.62 | 7,908.591 | 7,295.342 | 8,802.865 | 7,773.989 | 4,617.011 | 2,625.34 | 2,164.554 | 1,975.713 | 1,648.866 | 1,274.745 | 1,128.553 | 886.824 | 698.677 | 544.797 | 446.661 |
| Operating Income
| 4,426.321 | 3,654.143 | 2,198.86 | 1,793.267 | 1,638.317 | 1,976.672 | 1,356.2 | 1,156.833 | 668.058 | 573.504 | 1,088.752 | 1,148.539 | 1,134.82 | 1,060.226 | 754.409 | 505.556 | 353.109 | 246.474 |
| Operating Income Ratio
| 0.203 | 0.17 | 0.116 | 0.104 | 0.1 | 0.112 | 0.083 | 0.101 | 0.078 | 0.074 | 0.136 | 0.168 | 0.193 | 0.206 | 0.187 | 0.156 | 0.135 | 0.121 |
| Total Other Income Expenses Net
| -140.963 | -73.717 | -127.224 | -615.651 | -683.287 | -720.378 | -22.795 | -15.556 | -371.197 | 107.313 | 59.956 | 133.971 | 133.703 | 58.121 | 20.688 | -29.704 | -48.569 | -20.989 |
| Income Before Tax
| 4,285.359 | 3,580.426 | 2,071.464 | 1,177.616 | 955.031 | 1,256.294 | 1,333.404 | 1,141.276 | 716.426 | 680.817 | 1,148.708 | 1,282.509 | 1,268.523 | 1,118.042 | 775.097 | 521.916 | 351.514 | 256.153 |
| Income Before Tax Ratio
| 0.196 | 0.167 | 0.11 | 0.068 | 0.058 | 0.071 | 0.082 | 0.1 | 0.084 | 0.088 | 0.143 | 0.188 | 0.216 | 0.217 | 0.193 | 0.161 | 0.134 | 0.126 |
| Income Tax Expense
| 923.404 | 933.787 | 364.002 | 309.499 | 163.554 | 234.753 | 65.92 | 330.194 | 92.101 | 138.927 | 164.026 | 191.01 | 174.87 | 157.05 | 113.41 | 87.745 | 40.549 | 40.667 |
| Net Income
| 2,935.892 | 2,456.112 | 1,705.324 | 868.117 | 829.386 | 937.855 | 1,212.944 | 748.544 | 584.639 | 645.271 | 1,001.903 | 1,079.522 | 1,087.516 | 966.126 | 661.229 | 427.851 | 309.887 | 216.288 |
| Net Income Ratio
| 0.135 | 0.114 | 0.09 | 0.05 | 0.05 | 0.053 | 0.074 | 0.065 | 0.068 | 0.083 | 0.125 | 0.158 | 0.185 | 0.188 | 0.164 | 0.132 | 0.118 | 0.107 |
| EPS
| 1.83 | 1.69 | 1.22 | 0.61 | 0.58 | 0.66 | 0.85 | 0.52 | 0.41 | 0.45 | 0.7 | 0.75 | 0.76 | 0.67 | 0.51 | 0.4 | 0.29 | 0.21 |
| EPS Diluted
| 1.83 | 1.59 | 1.15 | 0.61 | 0.58 | 0.66 | 0.85 | 0.52 | 0.41 | 0.45 | 0.7 | 0.75 | 0.76 | 0.67 | 0.51 | 0.4 | 0.29 | 0.21 |
| EBITDA
| 5,718.695 | 4,857.789 | 3,519.936 | 2,808.428 | 2,605.57 | 2,766.261 | 2,808.302 | 2,487.043 | 1,723.391 | 1,605.181 | 1,911.922 | 1,779.742 | 1,638.697 | 1,375.055 | 922.233 | 631.132 | 465.372 | 335.413 |
| EBITDA Ratio
| 0.262 | 0.226 | 0.186 | 0.163 | 0.158 | 0.157 | 0.172 | 0.217 | 0.201 | 0.207 | 0.238 | 0.261 | 0.278 | 0.267 | 0.229 | 0.194 | 0.178 | 0.165 |